Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer

The anaplastic lymphoma kinase (ALK) is recognized by the immune system as a tumor antigen, and preclinical evidence suggests that ALK-rearranged NSCLCs can also be successfully targeted immunologically using vaccine-based approaches. In contrast to ALK-rearranged lymphomas, the frequency and clinic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Awad, Mark M., Mastini, Cristina, Blasco, Rafael B., Mologni, Luca, Voena, Claudia, Mussolin, Lara, Mach, Stacy L., Adeni, Anika E., Lydon, Christine A., Sholl, Lynette M., Jänne, Pasi A., Chiarle, Roberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696179/
https://ncbi.nlm.nih.gov/pubmed/29190913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21182
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi